Tissue surface tracking of tissue features is disclosed. First surface imaged features are tracked based on the first and second time spaced images at a first wavelength. Second surface imaged features are tracked based on the first and second time spaced tissue surface images at the second wavelength. Tracking metrics are obtained based on the tracking steps. The tracking steps are combined to provide a combined tracking metric. The combined tracking metric is used in a tissue surface navigation application.

Provided herein are systems and methods for monitoring one or more health or physiological parameters in a subject. The systems and methods may comprise a patch coupled to an injector. Data may be transmitted to a mobile device or remote server, where the data may be processed. Processed data may be used to inform a subject on a health or physiological condition.

An electronic device includes a display panel and a biometric information module. The display panel includes red-light emitting elements, green-light emitting elements, blue-light emitting elements, and light receiving elements that are spaced from each other. The blue-light emitting elements emit blue light in a biometric information mode of the electronic device. The light receiving elements receive at least one of red light and green light in the biometric information mode of the electronic device after the blue-light emitting elements have emitted the blue light. The light receiving elements generate electrical signals in response to the at least one of the red light and the green light. The biometric information module is electrically connected to the display panel and generates biometric information about a skin of a user based on the electrical signals.

Methods and apparatuses are disclosed for modifying images of skin so as to reduce or enhance the appearance of component pigments, such as melanin and hemoglobin. A diffuse reflectance image of skin, such as a cross-polarized contact dermoscopy image, which conveys information regarding subsurface features of the skin, is processed so as to extract pigment distribution information, which is then used to correct the diffuse reflectance image, such as by reducing the appearance of melanin to allow better visualization of hemoglobin-related structures, such as vasculature. Alternatively, the diffuse reflectance image can be corrected so as to reduce the appearance of hemoglobin to allow better visualization of melanin-related structures.

The present invention provides for a new system and method for diagnosing skin cancer that provides for a more effective analysis of changes in skin tissue due to the duality of acquiring visual data and transforming such visual into an audio signal. The conversion of complicated patterns of visual information of a skin lesion by a computer aided classification analysis into diagnostic sounds results in a much higher resolution rate and increased precision of diagnosis.

S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.

Some embodiments of the present disclosure are directed to ultraweak photon emission imaging systems and methods. In some embodiments, a method comprises acquiring an ultraweak photon emission image of a target area of a patient for detection of a pathological condition; wherein the target area comprises an area of interest and a portion surrounding the area of interest, wherein acquiring the image comprises: enhancing formation of reactive oxygen species and/or reactive nitrogen species in the target area, wherein enhancing formation of the reactive oxygen species and/or the reactive nitrogen species comprises applying low level light illumination to the target area from 1 second to 60 minutes so as to achieve a total power output from 1 mW to 10,000 W using an average power density from 0.1 W/cm.sup.2 to 1 W/cm.sup.2; and imaging the target area, wherein imaging the target area comprises a total exposure time from 1 second to 60 minutes.

A measuring device intended for being placed in contact with a tissue and a method for analysing the measured tissue data A measuring device intended for being placed in contact with a tissue, and comprising including an indenter configured to cause a deformation of the tissue, a strain gauge configured to measure a force of resistance of the tissue to the deformation caused by the indenter; and a position sensor configured to measure an indentation depth representative of a movement of the indenter. A method for analysing tissue data relating to a tissue, the method being implemented by computer and including a step of associating a measurement of the indentation depth and a measurement of the force of resistance to the deformation corresponding to the indentation depth.

An object of the present disclosure is to provide an optical measurement method, an optical measurement apparatus, and a non-transitory computer readable medium capable of specifying the position of a pore. The optical measurement method includes first, second, and third steps. In the first step (ST11), first 3D tomographic image data is acquired from a skin by using optical coherence tomography. In the second step (ST12), a line shown in a second planar image (B2) at a second depth is removed from a first planar image (B1) at a first depth, the second depth being deeper than the first depth. In the third step (ST13), a position of a pore is specified from the first planar image (B1) from which the line has been removed.

The present disclosure provides a method for treating clinical or pre-clinical skin damage in a skin field of a subject, wherein the skin field has been allocated a skin cancerization field index (SCFI) score of at least 1 as determined by a process comprising the steps of: (i) assessing the number of keratoses in the skin field; (ii) assessing the thickness of the thickest keratosis in the skin field; and (iii) assessing the proportion of the field affected by clinical or subclinical skin damage. Based on the assessments made in (i), (ii) and (iii) the subject is optionally treated by at least one of (a) freezing one or more lesions, (b) shaving, curetting or surgically removing one or more lesions, (c) applying a topical treatment for actinic keratosis, basal cell carcinoma or squamous cell carcinoma, and (d) radiation therapy.